Cancer Immunotherapy Market Segmentation by Modality and Indication | #bispecific cancer antibodies # antibody–drug conjugates # multimodal immunotherapy # T-cell engagers # checkpoint inhibitor combos # ADC innovation # Her2 bispecific therapy # precision oncology regimens # fusion immunotherapy # emerging cancer drug classes